{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"CD42b, also known as glycoprotein Ib alpha (GPIbα), along with glycoprotein lb beta (GPlbβ or CD42c), glycoprotein IX (GP9 or CD42a), and glycoprotein V (GP5 or CD42d) forms the platelet glycoprotein Ib-IX-V complex, which plays a crucial role in platelet adhesion and aggregation at sites of vascular injury. Upon adhesion to von Willebrand factor (vWF), CD42b undergoes conformational changes that activate downstream signaling pathways involved in platelet activation and aggregation. This includes the activation of integrin αIIbβ3 (GPIIb/IIIa), a key receptor for fibrinogen binding and platelet-platelet interactions, leading to platelet aggregation and formation of a hemostatic plug to seal the injured vessel.\nDysregulation of CD42b function or expression may contribute to thrombotic disorders, while abnormalities in CD42b can be indicative of platelet disorders such as von Willebrand disease or Bernard-Soulier syndrome. Immunohistochemical staining or flow cytometric analysis of CD42b expression on platelets is used in laboratory diagnostics to assess platelet function and screen for platelet disorders."}]}]}